US Patent Issued to INTERNATIONAL AIDS VACCINE INITIATIVE, MERCK SHARP & DOHME on May 27 for "Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins" (New York, Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,021, issued on May 27, was assigned to INTERNATIONAL AIDS VACCINE INITIATIVE INC. (New York) and MERCK SHARP & DOHME LLC (Rahway, N.J.).

"Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins" was invented by Christopher Lee Parks (Boonton, N.J.), Maoli Yuan (Brooklyn, N.Y.), Mark Feinberg (New York), Amy Espeseth (Chalfont, Pa.) and Andrew J. Bett (West Point, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) vaccines, recombinant vesicular stomatitis virus (VSV) vectors encoding the SARS-CoV-2 spike (S) prote...